Introduction
Clinical, epidemiologic, and toxicologic data indicate that occupational exposure to benzene can cause leukemia. The etiologic association was first suggested by case reports originiating more than 50 years ago (1) (2) (3) (4) (5) . Those observations were corroborated by epidemiologic studies among shoe workers (6) , chemical workers, and rubber workers (7) (8) (9) (10) (11) . Recently, benzene has been found to be carcinogenic in animal bioassays (12) (13) (14) (15) (16) . Benzene was formally declared a human carcinogen by the National Institute for Occupational Safety and Health (NIOSH) in 1976 (17) , by the U.S. Environmental Protection Agency (EPA) in 1979 (18) , and by the International Agency for Research on Cancer (IARC) in 1982 (19) .
The regulatory history of benzene has been turbulent. Particular controversy has surrounded efforts to regulate occupational exposure to benzene at relatively low levels,~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~* because until recently only qualitative information was available on the risk of leukemia at low levels of exposure to benzene. In 1978 the Occupational Safety and Health Administration (OSHA) promulgated an occupational exposure standard reducing permissible workers' exposures by 10-fold, from the previously acceptable 8 hr time-weighted average (TWA8) of 10 ppm to 1 ppm (20) .
This action was based on information from case reports and two epidemiologic studies (21) . Both of those studies demonstrated statistically significant excess mortality from leukemia in workers exposed to benzene, but neither presented sufficient data on exposure to permit examination of quantitative dose-response relationships (8, 9 ).
On July 2, 1980, in a decision of profound importance for governmental risk assessment, the U.S. Supreme Court invalidated the OSHA benzene standard of 1 ppm (22) . The Court stated that OSHA had failed to provide substantial evidence of the need for regulation, in that it had not quantified a "significant risk of material health impairment" at the previous level of 10 ppm and had not established that a new standard would achieve "a substantial reduction in significant risk." As a result of this decision, workers in the United States were allowed to be exposed at levels up to 10 ppm. That situation per-sisted until December 1987 when, on the basis of new, highly quantitative epidemiologic and toxicologic data, OSHA reimposed a 1-ppm standard (23) .
We have undertaken a quantitative assessment of the number of excess deaths from leukemia that ultimately will result from this 10-year delay in regulation. This analysis merges information developed by OSHA on numbers of workers exposed to benzene at various concentrations in seven industrial categories with quantitative data from epidemiologic studies on risk of benzene-induced leukemia. This analysis provides a basis for reconsideration of the premises underlying the 1980 Supreme Court decision on benzene.
Methods Populations Exposed to Benzene
In its final benzene rule, OSHA provided estimates of the numbers of workers exposed to various concentrations of benzene in the U.S. in seven different occupational categories (23) . Overall in 1987, 238,000 workers were occupationally exposed to benzene; approximately 10,000 wokers were exposed to time-weighted concentrations in excess of the 1-ppm standard promulgated by OSHA in 1978 (Table 1) . Earlier estimates by OSHA had suggested a greater population exposure; the proposed rule (24) had indicated that 274,000 were exposed, 27,500 to concentrations in excess of 1 ppm.
Epidemiologic Risk Assessments
Between 1982 and 1988, at least seven quantitative risk assessments were published evaluating the risk of leukemia in persons exposed to benzene. IARC (19) estimated that 140 to 170 excess leukemia deaths would occur per 1000 workers exposed to benzene for a 45-year working lifetime at levels of 10 to 100 ppm (10) and that 72 excess deaths per 1000 workers would occur from exposures of the same duration at levels between 1 and 30 ppm (9) . Using geometric means to estimate average exposures, these data suggest that 44 to 132 excess deaths from leukemia will occur per 1000 workers exposed at 10 ppm benzene for a 45-year working lifetime.
OSHA staff members published a risk assessment which estimated that 44 to 152 excess leukemia deaths will occur per 1000 workers for the same exposure conditions (25 25 , suggest that 71 to 132 of 1000 workers initially exposed to benzene at 10 ppm will die of benzene-related leukemia. A doseresponse relationship determined from a case-control analysis of the data from this study suggests an even higher mortality. 
